Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified

Pathology Research and Practice

Volumn 207, Issue 12, 2011, Pages 739-746

  Li, Weidong ^a   Yang, Dongling ^b   Wang, Shuling ^a   Guo, Xiaojing ^a   Lang, Ronggang ^a   Fan, Yu ^a   Gu, Feng ^a   Zhang, Xinmin ^c   Niu, Yun ^a   Yan, Xiyun ^b   Fu, Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Breast IMPC; Microvessel density (MVD)

Indexed keywords

CD146 ANTIGEN; CD31 ANTIGEN; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL PARAMETERS; BREAST CANCER; BREAST INVASIVE MICROPAPILLARY CARCINOMA; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG TARGETING; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MICROVESSEL DENSITY; PROGNOSIS; PROTEIN EXPRESSION; UPREGULATION; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTIGENS, CD146; ANTIGENS, CD31; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 82655184179     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.09.009     Document Type: Article

References (33)

1. Aldovini D., Demichelis F., Doglioni C., Di Vizio D., Galligioni E., Brugnara S., Zeni B., Griso C., Pegoraro C., Zannoni M., Gariboldi M., Balladore E., Mezzanzanica D., Canevari S., Barbareschi M. M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int. J. Cancer 2006, 119:1920-1926.
2. Bluff J.E., Menakuru S.R., Cross S.S., Higham S.E., Balasubramanian S.P., Brown N.J., Reed M.W., Staton C.A. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. Br. J. Cancer 2009, 101:666-672.
3. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
4. Carpenter P.M., Chen W.P., Mendez A., McLaren C.E., Su M.Y. Angiogenesis in the progression of breast ductal proliferations. Int. J. Surg. Pathol. 2009.
5. Chen L., Fan Y., Lang R.G., Guo X.J., Sun Y.L., Cui L.F., Liu F.F., Wei J., Zhang X.M., Fu L. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int. J. Surg. Pathol. 2008, 16:155-163.
6. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
7. Fernandez-Aguilar S., Jondet M., Simonart T., Noel J.C. Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinoma. Breast 2006, 15:782-785.
8. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1:27-31.
9. Garcia S., Dales J.P., Charafe-Jauffret E., Carpentier-Meunier S., Andrac-Meyer L., Jacquemier J., Andonian C., Lavaut M.N., Allasia C., Bonnier P., Charpin C. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum. Pathol. 2007, 38:830-841.
10. Gong Y., Sun X., Huo L., Wiley E.L., Rao M.S. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathology 2005, 46:24-30.
11. Kerr D.J. Targeting angiogenesis in cancer: clinical development of bevacizumab. Nat. Clin. Pract. Oncol. 2004, 1:39-43.
12. Kristiansen G., Yu Y., Schluns K., Sers C., Dietel M., Petersen I. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Anal. Cell. Pathol. 2003, 25:77-81.
13. Lehmann J.M., Riethmuller G., Johnson J.P. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:9891-9895.
14. Ludovini V., Sidoni A., Pistola L., Bellezza G., De Angelis V., Gori S., Mosconi A.M., Bisagni G., Cherubini R., Bian A.R., Rodino C., Sabbatini R., Mazzocchi B., Bucciarelli E., Tonato M., Colozza M. Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. Breast Cancer Res. Treat. 2003, 81:159-168.
15. Luna-More S., Gonzalez B., Acedo C., Rodrigo I., Luna C. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol. Res. Pract. 1994, 190:668-674.
16. Middleton L.P., Tressera F., Sobel M.E., Bryant B.R., Alburquerque A., Grases P., Merino M.J. Infiltrating micropapillary carcinoma of the breast. Mod. Pathol. 1999, 12:499-504.
17. Mostert B., Kraan J., Bolt-de Vries J., van der Spoel P., Sieuwerts A.M., Schutte M., Timmermans A.M., Foekens R., Martens J.W., Gratama J.W., Foekens J.A., Sleijfer S. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Res. Treat. 2011, 127:33-41.
18. Nassar H., Wallis T., Andea A., Dey J., Adsay V., Visscher D. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod. Pathol. 2001, 14:836-841.
19. Neidhart M., Wehrli R., Bruhlmann P., Michel B.A., Gay R.E., Gay S. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis Rheum. 1999, 42:622-630.
20. Nelson N.J. Angiogenesis research is on fast forward. J. Natl. Cancer Inst. 1999, 91:820-822.
21. Ouhtit A., Gaur R.L., Abd Elmageed Z.Y., Fernando A., Thouta R., Trappey A.K., Abdraboh M.E., El-Sayyad H.I., Rao P., Raj M.G. Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim. Biophys. Acta 2009, 1795:130-136.
22. Sato A., Torii I., Okamura Y., Yamamoto T., Nishigami T., Kataoka T.R., Song M., Hasegawa S., Nakano T., Kamei T., Tsujimura T. Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium. Mod. Pathol. 2010, 23:1458-1466.
23. Shih I.M., Elder D.E., Hsu M.Y., Herlyn M. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am. J. Pathol. 1994, 145:837-845.
24. Shih I.M., Elder D.E., Speicher D., Johnson J.P., Herlyn M. Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res. 1994, 54:2514-2520.
25. Siriaunkgul S., Tavassoli F.A. Invasive micropapillary carcinoma of the breast. Mod. Pathol. 1993, 6:660-662.
26. Tavassaoeli F.A., Davilee P. Tumors of the Breast and Female Genital Organs, Classification of Tumors, No 4 2003, IARC WHO, Lyon.
27. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 1991, 324:1-8.
28. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., Dowsett M., Fitzgibbons P.L., Hanna W.M., Langer A., McShane L.M., Paik S., Pegram M.D., Perez E.A., Press M.F., Rhodes A., Sturgeon C., Taube S.E., Tubbs R., Vance G.H., van de Vijver M., Wheeler T.M., Hayes D.F. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol. 2007, 25:118-145.
29. Wu G.J., Varma V.A., Wu M.W., Wang S.W., Qu P., Yang H., Petros J.A., Lim S.D., Amin M.B. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues. Prostate 2001, 48:305-315.
30. Zabouo G., Imbert A.M., Jacquemier J., Finetti P., Moreau T., Esterni B., Birnbaum D., Bertucci F., Chabannon C. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res. 2009, 11:R1.
31. Zetter B.R. Angiogenesis and tumor metastasis. Annu. Rev. Med. 1998, 49:407-424.
32. Zheng C., Qiu Y., Zeng Q., Zhang Y., Lu D., Yang D., Feng J., Yan X. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization. Int. J. Biochem. Cell Biol. 2009, 41:2163-2172.
33. Zhuang J., Jiang T., Lu D., Luo Y., Zheng C., Feng J., Yang D., Chen C., Yan X. NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction. Free Radical Biol. Med. 2010, 49:227-236.